Last edition
News about Global Pharma
Novo Nordisk Expects EC Approval of Alhemo Label Update for Haemophilia in 2 Months
Novo Nordisk has received a positive opinion from EMA’s Committee for Medicinal Products for Human Use (CHMP) for expanded Alhemo use in haemophilia without inhibitors.
Global Pharma | 26/07/2025 | By Dineshwori | 441
PM Modi said that the India-UK Comprehensive Economic Trade Agreement (CETA) would particularly benefit India’s youth, farmers, fishermen, and the MSME sector.
Global Pharma | 25/07/2025 | By Dineshwori | 124
Klotho Neurosciences to Broaden Development Programs Beyond Neurology
Klotho Neurosciences, Inc. has announced plans to expand beyond neurology by exploring acquisitions of complementary technologies that support brain health, organ function, and longevity, building on its proprietary anti-ageing Klotho platform.
Global Pharma | 25/07/2025 | By Mrinmoy Dey | 195
The next phase of clinical development will span the U.S. and global trial sites, with a priority focus on launching Phase 3 trials for NSCLC and other solid tumors, beginning with patient enrollment in the U.S.
Global Pharma | 25/07/2025 | By Darshana | 424
Lupin Secures USFDA Approval for Liraglutide and Glucagon Injectable Products
Global pharma giant Lupin has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Liraglutide Injection Single-Patient-Use Prefilled Pens and Glucagon for Injection vials.
Global Pharma | 24/07/2025 | By Dineshwori | 315
Torrent Pharma Enters Adult Nutrition Segment with Launch of Shelcal Total
Torrent Pharmaceuticals has announced the expansion of its flagship Shelcal brand into the growing nutrition segment with the launch of a scientifically formulated adult nutrition supplement powder.
Global Pharma | 24/07/2025 | By Dineshwori | 530
MHRA Unveils Major Regulatory Reforms to Accelerate Patient Access to Global Medical Technologies
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced sweeping reforms aimed at improving patient access to cutting-edge medical technologies and easing the regulatory burden on manufacturers.
Global Pharma | 24/07/2025 | By Darshana | 331
European Commission Approves DARZALEX Faspro for Adults with Smouldering Multiple Myeloma
Halozyme Therapeutics has announced European Commission approval for DARZALEX Faspro, co-formulated with ENHANZE, as a monotherapy for high-risk smouldering multiple myeloma in adults, marking a shift from passive monitoring to early intervention.
Global Pharma | 24/07/2025 | By Mrinmoy Dey | 181
India-UK FTA to Ease Regulatory Approvals, Boost Indian Pharma Exports: FIEO
Key Indian sectors such as textiles, apparel, leather, gems and jewellery, pharmaceuticals, marine and engineering goods are expected to gain substantially from the proposed India–UK Free Trade Agreement (FTA).
Global Pharma | 23/07/2025 | By Dineshwori | 209
Neuraxpharm Strengthens Global Footprint with Neuraxpharm Australia Launch
Neuraxpharm Group has launched Neuraxpharm Australia as part of its global expansion strategy, bringing key CNS treatments to the Australian market under the leadership of newly appointed Head of Commercial, Avendran Naidu.
Global Pharma | 23/07/2025 | By Mrinmoy Dey | 315
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy